another alpha basher?

Cellceutix Is Due For A Hard Correction
by Elegant Trading

A lot of times in biotechnology, companies tend to have hyperbolic price action and investors are worried about missing the run. In most instances, they end up paying too high of a price only to see the stock sell off in the weeks after. It appears that Cellceutix ( CTIX.OB ) has had one of those runs and now may be the time to take profits. read more »